In the USA, the layoffs at health agencies, proposed tariffs on imports and other disruptive policies under President Donald ...

Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...

Myricx Bio, a UK biotech focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates ...

Indian drugmaker Sun Pharmaceutical Industries (BSE: 524715) revealed it has launched fexuprazan tablets 40mg in India under ...

Ireland’s government remains confident in its ability to retain the country’s strategic position in pharmaceutical ...

Following hot on the heels of Monday’s European Commission EC approval of an indication extension for Johnson & Johnson’s ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

Australia’s Therapeutics Goods Administration (TGA) has issued a safety notice on isotretinoin, originally sold as Roaccutane ...

The USA’s Centers for Medicare & Medicaid Services (CMS) yesterday released the Calendar Year (CY) 2026 Rate Announcement for ...

The UK’s Prime Minister has announced action to accelerate the discovery of life-saving drugs, improve patient care and make ...

US biotech start-up RayThera has secured $110 million in series A financing to fund the early clinical development of its ...

The uveitis treatment market across seven major economies—the USA, France, Germany, Italy, Spain, the UK, and Japan—is projected to grow from $522 million in 2023 to $1.5 billion by 2033, according to ...